UAE: Aster Pharmacy, a retail division of Aster DM Healthcare has announced that it is participating in the 2022 edition of Arab Health along with Alfa One, the distribution arm.

Aster Pharmacy is showcasing three technologically advanced health and skincare products at the event - this includes, Naobay (Organic skincare from Spain); UAE homegrown brand – Nano Seha (Alcohol Free Nanosilver based Sanitizers that offer greater protection); and BioSepeedia (vitro diagnostics, a 15-minute rapid home test kits from France).

In addition, Aster will be showcasing over 20 different brands with their distribution partner, Alfa One. Alfa One, is one of the company’s top distributors - bringing world renowned and trusted brands in the Nutrition, Personal Care and Home Healthcare space.

Balasubramanian, CEO, Aster Health said, “Arab Health is the region's largest  healthcare exhibition that brings together several healthcare professionals, trade visitors and exhibitors from across the Middle East - giving us an opportunity to showcase our wide range of health, wellness and beauty products and services to potential customers. This year we are also looking to expand our partner network and geographical presence via our unique Franchise model.”

Aster Pharmacy’s participation in Arab Health also comes as leading health care providers view digital transformation to become more consumer-friendly. The pandemic accelerated the convergence of several trends in the healthcare industry, particularly consumers prioritizing convenience and access to care. Aster will be showcasing at Dubai World Trade Centre  from 24 - 27 January at booth E10 Hall 6.

Send us your press releases to pressrelease.zawya@refinitiv.com

© Press Release 2022

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.